Page last updated: 2024-10-15

alpha-hydroxyglutarate and Myelodysplastic Syndromes

alpha-hydroxyglutarate has been researched along with Myelodysplastic Syndromes in 1 studies

2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.
2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, P1
Luo, Y1
Zhu, S1
Maggio, D1
Yang, H1
Hu, C1
Wang, J1
Zhang, H1
Ren, Y1
Zhou, X1
Mei, C1
Ma, L1
Xu, W1
Ye, L1
Zhuang, Z1
Jin, J1
Tong, H1

Other Studies

1 other study available for alpha-hydroxyglutarate and Myelodysplastic Syndromes

ArticleYear
Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes.
    Journal of cancer research and clinical oncology, 2018, Volume: 144, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Transformation, Neoplastic; Cohort Studies; Female;

2018